|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1401 to 1500 out of 4141 for Mtor

<< First    < Previous  |  Next >    Last >>
0.023s

Categories

Hits by Pathway

Hits by Category

Hits by Strain

Type Details Score
Publication
33473107 | J:301224
First Author: Wang W
Year: 2021
Journal: Nat Commun
Title: Endonuclease G promotes autophagy by suppressing mTOR signaling and activating the DNA damage response.
Volume: 12
Issue: 1
Pages: 476
•
•
•
•
•
Publication
20227039 | J:158661
First Author: Hsieh AC
Year: 2010
Journal: Cancer Cell
Title: Genetic dissection of the oncogenic mTOR pathway reveals druggable addiction to translational control via 4EBP-eIF4E.
Volume: 17
Issue: 3
Pages: 249-61
•
•
•
•
•
Publication
19364503 | J:149680
First Author: Kuang X
Year: 2009
Journal: Biochem Biophys Res Commun
Title: Deregulation of mTOR signaling is involved in thymic lymphoma development in Atm-/- mice.
Volume: 383
Issue: 3
Pages: 368-72
•
•
•
•
•
Publication
17128276 | J:116607
First Author: Song J
Year: 2007
Journal: Nat Immunol
Title: The kinases aurora B and mTOR regulate the G1-S cell cycle progression of T lymphocytes.
Volume: 8
Issue: 1
Pages: 64-73
•
•
•
•
•
Publication
22998871 | J:315228
First Author: Pun RY
Year: 2012
Journal: Neuron
Title: Excessive activation of mTOR in postnatally generated granule cells is sufficient to cause epilepsy.
Volume: 75
Issue: 6
Pages: 1022-34
•
•
•
•
•
Publication
32581239 | J:293303
First Author: Bonucci M
Year: 2020
Journal: Nat Commun
Title: mTOR and S6K1 drive polycystic kidney by the control of Afadin-dependent oriented cell division.
Volume: 11
Issue: 1
Pages: 3200
•
•
•
•
•
Publication
27134166 | J:235482
First Author: Allen E
Year: 2016
Journal: Cell Rep
Title: Metabolic Symbiosis Enables Adaptive Resistance to Anti-angiogenic Therapy that Is Dependent on mTOR Signaling.
Volume: 15
Issue: 6
Pages: 1144-60
•
•
•
•
•
Publication
29281825 | J:277093
First Author: D'Gama AM
Year: 2017
Journal: Cell Rep
Title: Somatic Mutations Activating the mTOR Pathway in Dorsal Telencephalic Progenitors Cause a Continuum of Cortical Dysplasias.
Volume: 21
Issue: 13
Pages: 3754-3766
•
•
•
•
•
Publication
18276609 | J:135566
First Author: Tang G
Year: 2008
Journal: Hum Mol Genet
Title: Autophagy induced by Alexander disease-mutant GFAP accumulation is regulated by p38/MAPK and mTOR signaling pathways.
Volume: 17
Issue: 11
Pages: 1540-55
•
•
•
•
•
Publication
27030515 | J:354978
First Author: Wang J
Year: 2016
Journal: Br J Haematol
Title: mTOR Inhibition improves anaemia and reduces organ damage in a murine model of sickle cell disease.
Volume: 174
Issue: 3
Pages: 461-9
•
•
•
•
•
Publication
33976205 | J:314416
First Author: Kim SG
Year: 2021
Journal: Nat Commun
Title: Tanc2-mediated mTOR inhibition balances mTORC1/2 signaling in the developing mouse brain and human neurons.
Volume: 12
Issue: 1
Pages: 2695
•
•
•
•
•
Publication
23644504 | J:197319
First Author: Kim JS
Year: 2013
Journal: Nat Immunol
Title: Natural and inducible TH17 cells are regulated differently by Akt and mTOR pathways.
Volume: 14
Issue: 6
Pages: 611-8
•
•
•
•
•
Publication
23524951 | J:197628
First Author: Nazio F
Year: 2013
Journal: Nat Cell Biol
Title: mTOR inhibits autophagy by controlling ULK1 ubiquitylation, self-association and function through AMBRA1 and TRAF6.
Volume: 15
Issue: 4
Pages: 406-16
•
•
•
•
•
Publication
23439118 | J:197828
First Author: Zhou M
Year: 2013
Journal: Neuron
Title: mTOR Inhibition ameliorates cognitive and affective deficits caused by Disc1 knockdown in adult-born dentate granule neurons.
Volume: 77
Issue: 4
Pages: 647-54
•
•
•
•
•
Publication
27166282 | J:237396
First Author: Hu F
Year: 2016
Journal: Am J Physiol Endocrinol Metab
Title: Hypothalamic roles of mTOR complex I: integration of nutrient and hormone signals to regulate energy homeostasis.
Volume: 310
Issue: 11
Pages: E994-E1002
•
•
•
•
•
Publication
28461508 | J:242205
First Author: Dai YJ
Year: 2017
Journal: Proc Natl Acad Sci U S A
Title: Conditional knockin of Dnmt3a R878H initiates acute myeloid leukemia with mTOR pathway involvement.
Volume: 114
Issue: 20
Pages: 5237-5242
•
•
•
•
•
Publication
29720666 | J:262852
First Author: Bowling S
Year: 2018
Journal: Nat Commun
Title: P53 and mTOR signalling determine fitness selection through cell competition during early mouse embryonic development.
Volume: 9
Issue: 1
Pages: 1763
•
•
•
•
•
Publication
37874650 | J:343617
 
First Author: Mason EC
Year: 2023
Journal: J Clin Invest
Title: Activation of mTOR signaling in adult lung microvascular progenitor cells accelerates lung aging.
Volume: 133
Issue: 24
•
•
•
•
•
Publication
22196333 | J:273495
First Author: Mazei-Robison MS
Year: 2011
Journal: Neuron
Title: Role for mTOR signaling and neuronal activity in morphine-induced adaptations in ventral tegmental area dopamine neurons.
Volume: 72
Issue: 6
Pages: 977-90
•
•
•
•
•
Publication
22056317 | J:183673
First Author: Clemente CF
Year: 2012
Journal: J Mol Cell Cardiol
Title: Focal adhesion kinase governs cardiac concentric hypertrophic growth by activating the AKT and mTOR pathways.
Volume: 52
Issue: 2
Pages: 493-501
•
•
•
•
•
Publication
15988001 | J:99368
First Author: Sofer A
Year: 2005
Journal: Mol Cell Biol
Title: Regulation of mTOR and cell growth in response to energy stress by REDD1.
Volume: 25
Issue: 14
Pages: 5834-45
•
•
•
•
•
Publication
22343943 | J:182149
First Author: Settembre C
Year: 2012
Journal: EMBO J
Title: A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB.
Volume: 31
Issue: 5
Pages: 1095-108
•
•
•
•
•
Publication
22904304 | J:189915
First Author: Procaccini C
Year: 2012
Journal: J Immunol
Title: Leptin-induced mTOR activation defines a specific molecular and transcriptional signature controlling CD4+ effector T cell responses.
Volume: 189
Issue: 6
Pages: 2941-53
•
•
•
•
•
Publication
21540234 | J:173408
First Author: Jiang Q
Year: 2011
Journal: Cancer Res
Title: mTOR kinase inhibitor AZD8055 enhances the immunotherapeutic activity of an agonist CD40 antibody in cancer treatment.
Volume: 71
Issue: 12
Pages: 4074-84
•
•
•
•
•
Publication
22740122 | J:188008
First Author: Lee JH
Year: 2012
Journal: Eur J Immunol
Title: Progesterone suppresses the mTOR pathway and promotes generation of induced regulatory T cells with increased stability.
Volume: 42
Issue: 10
Pages: 2683-96
•
•
•
•
•
Publication
26837766 | J:235545
First Author: D'Armiento J
Year: 2016
Journal: Cancer Res
Title: Mesenchymal Tumorigenesis Driven by TSC2 Haploinsufficiency Requires HMGA2 and Is Independent of mTOR Pathway Activation.
Volume: 76
Issue: 4
Pages: 844-54
•
•
•
•
•
Publication
24847003 | J:214310
First Author: Ravichandran K
Year: 2014
Journal: Hum Mol Genet
Title: An mTOR anti-sense oligonucleotide decreases polycystic kidney disease in mice with a targeted mutation in Pkd2.
Volume: 23
Issue: 18
Pages: 4919-31
•
•
•
•
•
Publication
32989095 | J:300712
First Author: Sharma D
Year: 2020
Journal: J Immunol
Title: RIPK3 Promotes Mefv Expression and Pyrin Inflammasome Activation via Modulation of mTOR Signaling.
Volume: 205
Issue: 10
Pages: 2778-2785
•
•
•
•
•
Publication
17346540 | J:122611
First Author: Milam MR
Year: 2007
Journal: Am J Obstet Gynecol
Title: Reduced progression of endometrial hyperplasia with oral mTOR inhibition in the Pten heterozygote murine model.
Volume: 196
Issue: 3
Pages: 247.e1-5
•
•
•
•
•
Publication
30134066 | J:264528
First Author: Kramer K
Year: 2018
Journal: Genesis
Title: Rapamycin rescues BMP mediated midline craniosynostosis phenotype through reduction of mTOR signaling in a mouse model.
Volume: 56
Issue: 6-7
Pages: e23220
•
•
•
•
•
Publication
30288694 | J:281989
First Author: Schroeder E
Year: 2019
Journal: Mol Neurobiol
Title: Neuron-Type Specific Loss of CDKL5 Leads to Alterations in mTOR Signaling and Synaptic Markers.
Volume: 56
Issue: 6
Pages: 4151-4162
•
•
•
•
•
Publication
29453322 | J:260731
First Author: Ding M
Year: 2018
Journal: Mol Cancer Res
Title: The mTOR Targets 4E-BP1/2 Restrain Tumor Growth and Promote Hypoxia Tolerance in PTEN-driven Prostate Cancer.
Volume: 16
Issue: 4
Pages: 682-695
•
•
•
•
•
Publication
36061025 | J:352103
First Author: Tong WH
Year: 2022
Journal: Heliyon
Title: Hyperactivation of mTOR and AKT in a cardiac hypertrophy animal model of Friedreich ataxia.
Volume: 8
Issue: 8
Pages: e10371
•
•
•
•
•
Publication
21394210 | J:171722
First Author: Clegg NJ
Year: 2011
Journal: PLoS One
Title: MYC cooperates with AKT in prostate tumorigenesis and alters sensitivity to mTOR inhibitors.
Volume: 6
Issue: 3
Pages: e17449
•
•
•
•
•
Publication
24129405 | J:208733
First Author: Ma A
Year: 2014
Journal: Hum Mol Genet
Title: Tsc1 deficiency-mediated mTOR hyperactivation in vascular endothelial cells causes angiogenesis defects and embryonic lethality.
Volume: 23
Issue: 3
Pages: 693-705
•
•
•
•
•
Publication
23437388 | J:197188
First Author: Zhang B
Year: 2013
Journal: PLoS One
Title: Vigabatrin inhibits seizures and mTOR pathway activation in a mouse model of tuberous sclerosis complex.
Volume: 8
Issue: 2
Pages: e57445
•
•
•
•
•
Publication
29716997 | J:263878
First Author: Aboudehen K
Year: 2018
Journal: J Biol Chem
Title: Long noncoding RNA Hoxb3os is dysregulated in autosomal dominant polycystic kidney disease and regulates mTOR signaling.
Volume: 293
Issue: 24
Pages: 9388-9398
•
•
•
•
•
Publication
19794149 | J:155912
First Author: Ge Y
Year: 2009
Journal: Am J Physiol Cell Physiol
Title: mTOR regulates skeletal muscle regeneration in vivo through kinase-dependent and kinase-independent mechanisms.
Volume: 297
Issue: 6
Pages: C1434-44
•
•
•
•
•
Publication
31685878 | J:286986
First Author: Crutcher E
Year: 2019
Journal: Sci Rep
Title: mTOR and autophagy pathways are dysregulated in murine and human models of Schaaf-Yang syndrome.
Volume: 9
Issue: 1
Pages: 15935
•
•
•
•
•
Publication
34535637 | J:331670
First Author: Mencer S
Year: 2021
Journal: Transl Psychiatry
Title: Proteomics of autism and Alzheimer's mouse models reveal common alterations in mTOR signaling pathway.
Volume: 11
Issue: 1
Pages: 480
•
•
•
•
•
Publication
24385536 | J:209408
First Author: Mleczko-Sanecka K
Year: 2014
Journal: Blood
Title: Unbiased RNAi screen for hepcidin regulators links hepcidin suppression to proliferative Ras/RAF and nutrient-dependent mTOR signaling.
Volume: 123
Issue: 10
Pages: 1574-85
•
•
•
•
•
Publication
23678040 | J:200858
First Author: Rai P
Year: 2013
Journal: Am J Physiol Renal Physiol
Title: mTOR plays a critical role in p53-induced oxidative kidney cell injury in HIVAN.
Volume: 305
Issue: 3
Pages: F343-54
•
•
•
•
•
Publication
34199295 | J:313740
 
First Author: Lee JH
Year: 2021
Journal: Int J Mol Sci
Title: n-Butylidenephthalide Modulates Autophagy to Ameliorate Neuropathological Progress of Spinocerebellar Ataxia Type 3 through mTOR Pathway.
Volume: 22
Issue: 12
•
•
•
•
•
Publication
24583056 | J:231219
 
First Author: Xiong X
Year: 2014
Journal: Neurobiol Dis
Title: PRAS40 plays a pivotal role in protecting against stroke by linking the Akt and mTOR pathways.
Volume: 66
Pages: 43-52
•
•
•
•
•
Publication
38158148 | J:352223
 
First Author: Yang Y
Year: 2024
Journal: Mol Cell Endocrinol
Title: Branched-chain amino acid catabolic defect promotes α-cell proliferation via activating mTOR signaling.
Volume: 582
Pages: 112143
•
•
•
•
•
Publication
32512114 | J:302648
 
First Author: Martin PY
Year: 2020
Journal: Prog Neurobiol
Title: mTOR activation by constitutively active serotonin6 receptors as new paradigm in neuropathic pain and its treatment.
Volume: 193
Pages: 101846
•
•
•
•
•
Publication
18411301 | J:137317
First Author: Huang J
Year: 2008
Journal: Mol Cell Biol
Title: The TSC1-TSC2 complex is required for proper activation of mTOR complex 2.
Volume: 28
Issue: 12
Pages: 4104-15
•
•
•
•
•
Publication
25681550 | J:221061
 
First Author: Li X
Year: 2015
Journal: Brain Res
Title: p53 inhibition provides a pivotal protective effect against ischemia-reperfusion injury in vitro via mTOR signaling.
Volume: 1605
Pages: 31-8
•
•
•
•
•
Publication
25564517 | J:222469
First Author: Van Rechem C
Year: 2015
Journal: Cancer Discov
Title: A coding single-nucleotide polymorphism in lysine demethylase KDM4A associates with increased sensitivity to mTOR inhibitors.
Volume: 5
Issue: 3
Pages: 245-54
•
•
•
•
•
Publication
25918246 | J:224100
First Author: Koo J
Year: 2015
Journal: Mol Cell Biol
Title: mTOR Complex 2 Stabilizes Mcl-1 Protein by Suppressing Its Glycogen Synthase Kinase 3-Dependent and SCF-FBXW7-Mediated Degradation.
Volume: 35
Issue: 13
Pages: 2344-55
•
•
•
•
•
Publication
25888508 | J:224636
First Author: Aoyagi T
Year: 2015
Journal: Am J Physiol Heart Circ Physiol
Title: Cardiac mTOR rescues the detrimental effects of diet-induced obesity in the heart after ischemia-reperfusion.
Volume: 308
Issue: 12
Pages: H1530-9
•
•
•
•
•
Publication
29729422 | J:264759
 
First Author: Caccamo A
Year: 2018
Journal: Neurobiol Aging
Title: Genetically reducing mTOR signaling rescues central insulin dysregulation in a mouse model of Alzheimer's disease.
Volume: 68
Pages: 59-67
•
•
•
•
•
Publication
31011190 | J:279854
First Author: Ueda Y
Year: 2019
Journal: Sci Rep
Title: Additive effects of inhibiting both mTOR and glutamine metabolism on the arthritis in SKG mice.
Volume: 9
Issue: 1
Pages: 6374
•
•
•
•
•
Publication
31102490 | J:291318
First Author: Park JW
Year: 2019
Journal: Stem Cells
Title: Inhibition of mTOR by Rapamycin Aggravates Corneal Epithelial Stem Cell Deficiency by Upregulating Inflammatory Response.
Volume: 37
Issue: 9
Pages: 1212-1222
•
•
•
•
•
Publication
32444668 | J:292310
First Author: Miesen L
Year: 2020
Journal: Sci Rep
Title: Inhibition of mTOR delayed but could not prevent experimental collapsing focal segmental glomerulosclerosis.
Volume: 10
Issue: 1
Pages: 8580
•
•
•
•
•
Publication
32821949 | J:298294
First Author: Sokolov AM
Year: 2020
Journal: Hum Mol Genet
Title: The amino acid transporter Slc7a5 regulates the mTOR pathway and is required for granule cell development.
Volume: 29
Issue: 18
Pages: 3003-3013
•
•
•
•
•
Publication
39680456 | J:359778
 
First Author: Wu Q
Year: 2024
Journal: J Clin Invest
Title: Evi1 governs Kdm6b-mediated histone demethylation to regulate the Laptm4b-driven mTOR pathway in hematopoietic progenitor cells.
Volume: 134
Issue: 24
•
•
•
•
•
Publication
19720745 | J:153984
First Author: Dibble CC
Year: 2009
Journal: Mol Cell Biol
Title: Characterization of Rictor phosphorylation sites reveals direct regulation of mTOR complex 2 by S6K1.
Volume: 29
Issue: 21
Pages: 5657-70
•
•
•
•
•
Publication
29884702 | J:264075
First Author: Sun IH
Year: 2018
Journal: J Immunol
Title: mTOR Complex 1 Signaling Regulates the Generation and Function of Central and Effector Foxp3+ Regulatory T Cells.
Volume: 201
Issue: 2
Pages: 481-492
•
•
•
•
•
Publication
33834178 | J:336109
First Author: Parihar M
Year: 2020
Journal: Aging Pathobiol Ther
Title: Sex-dependent lifespan extension of Apc (Min/+) FAP mice by chronic mTOR inhibition.
Volume: 2
Issue: 4
Pages: 187-194
•
•
•
•
•
Publication
12403809 | J:79972
First Author: Jaeschke A
Year: 2002
Journal: J Cell Biol
Title: Tuberous sclerosis complex tumor suppressor-mediated S6 kinase inhibition by phosphatidylinositide-3-OH kinase is mTOR independent.
Volume: 159
Issue: 2
Pages: 217-24
•
•
•
•
•
Publication
30894372 | J:274187
First Author: Wang Z
Year: 2019
Journal: Cancer Res
Title: 4E-BP1 Is a Tumor Suppressor Protein Reactivated by mTOR Inhibition in Head and Neck Cancer.
Volume: 79
Issue: 7
Pages: 1438-1450
•
•
•
•
•
Publication
32087218 | J:288279
 
First Author: Peng K
Year: 2020
Journal: J Mol Cell Cardiol
Title: IRF-1 mediates the suppressive effects of mTOR inhibition on arterial endothelium.
Volume: 140
Pages: 30-41
•
•
•
•
•
Publication
31661292 | J:336351
First Author: Mroueh FM
Year: 2019
Journal: FASEB J
Title: Unmasking the interplay between mTOR and Nox4: novel insights into the mechanism connecting diabetes and cancer.
Volume: 33
Issue: 12
Pages: 14051-14066
•
•
•
•
•
Publication
26459113 | J:228650
 
First Author: Srivastava IN
Year: 2016
Journal: Neurobiol Dis
Title: mTOR pathway inhibition prevents neuroinflammation and neuronal death in a mouse model of cerebral palsy.
Volume: 85
Pages: 144-154
•
•
•
•
•
Publication
25210733 | J:228778
First Author: Avet-Rochex A
Year: 2014
Journal: PLoS Genet
Title: Unkempt is negatively regulated by mTOR and uncouples neuronal differentiation from growth control.
Volume: 10
Issue: 9
Pages: e1004624
•
•
•
•
•
Publication
34933094 | J:319802
 
First Author: Bornstein R
Year: 2022
Journal: Neurobiol Dis
Title: Differential effects of mTOR inhibition and dietary ketosis in a mouse model of subacute necrotizing encephalomyelopathy.
Volume: 163
Pages: 105594
•
•
•
•
•
Publication
23852728 | J:198782
First Author: Betz C
Year: 2013
Journal: Proc Natl Acad Sci U S A
Title: Feature Article: mTOR complex 2-Akt signaling at mitochondria-associated endoplasmic reticulum membranes (MAM) regulates mitochondrial physiology.
Volume: 110
Issue: 31
Pages: 12526-34
•
•
•
•
•
Publication
27032892 | J:293079
First Author: Yao Y
Year: 2016
Journal: J Am Soc Nephrol
Title: Role of Ragulator in the Regulation of Mechanistic Target of Rapamycin Signaling in Podocytes and Glomerular Function.
Volume: 27
Issue: 12
Pages: 3653-3665
•
•
•
•
•
Publication
19738074 | J:152681
First Author: Zhang W
Year: 2009
Journal: Cancer Res
Title: Inhibition of tumor growth progression by antiandrogens and mTOR inhibitor in a Pten-deficient mouse model of prostate cancer.
Volume: 69
Issue: 18
Pages: 7466-72
•
•
•
•
•
Publication
28004151 | J:240110
First Author: Yuan T
Year: 2017
Journal: Diabetologia
Title: Reciprocal regulation of mTOR complexes in pancreatic islets from humans with type 2 diabetes.
Volume: 60
Issue: 4
Pages: 668-678
•
•
•
•
•
Publication
35672148 | J:353416
First Author: Shi Q
Year: 2022
Journal: J Neurosci
Title: Microglial mTOR Activation Upregulates Trem2 and Enhances β-Amyloid Plaque Clearance in the 5XFAD Alzheimer's Disease Model.
Volume: 42
Issue: 27
Pages: 5294-5313
•
•
•
•
•
Publication
33888602 | J:311350
First Author: Van Skike CE
Year: 2021
Journal: J Neurosci
Title: mTOR Attenuation with Rapamycin Reverses Neurovascular Uncoupling and Memory Deficits in Mice Modeling Alzheimer's Disease.
Volume: 41
Issue: 19
Pages: 4305-4320
•
•
•
•
•
Publication
30936881 | J:294664
 
First Author: Łyszkiewicz M
Year: 2019
Journal: Front Immunol
Title: LAMTOR2 (p14) Controls B Cell Differentiation by Orchestrating Endosomal BCR Trafficking.
Volume: 10
Pages: 497
•
•
•
•
•
Protein
G3UW70
Organism: Mus musculus/domesticus
Length: 145  
Fragment?: false
•
•
•
•
•
Publication
19234517 | J:147582
First Author: Hartman TR
Year: 2009
Journal: Oncogene
Title: The role of the Birt-Hogg-Dubé protein in mTOR activation and renal tumorigenesis.
Volume: 28
Issue: 13
Pages: 1594-604
•
•
•
•
•
Publication
24231806 | J:205114
First Author: Johnson SC
Year: 2013
Journal: Science
Title: mTOR inhibition alleviates mitochondrial disease in a mouse model of Leigh syndrome.
Volume: 342
Issue: 6165
Pages: 1524-8
•
•
•
•
•
Publication
36079859 | J:335228
 
First Author: Yang L
Year: 2022
Journal: Nutrients
Title: Vasorin Deletion in C57BL/6J Mice Induces Hepatocyte Autophagy through Glycogen-Mediated mTOR Regulation.
Volume: 14
Issue: 17
•
•
•
•
•
Publication
23429703 | J:193964
First Author: Ben-Sahra I
Year: 2013
Journal: Science
Title: Stimulation of de novo pyrimidine synthesis by growth signaling through mTOR and S6K1.
Volume: 339
Issue: 6125
Pages: 1323-8
•
•
•
•
•
Publication
29206103 | J:255008
   
First Author: Tang F
Year: 2017
Journal: Elife
Title: A population of innate myelolymphoblastoid effector cell expanded by inactivation of mTOR complex 1 in mice.
Volume: 6
•
•
•
•
•
Publication
26220974 | J:226033
First Author: Gong X
Year: 2015
Journal: Hum Mol Genet
Title: Activating the translational repressor 4E-BP or reducing S6K-GSK3β activity prevents accelerated axon growth induced by hyperactive mTOR in vivo.
Volume: 24
Issue: 20
Pages: 5746-58
•
•
•
•
•
Publication
33170774 | J:298680
   
First Author: Gnanapradeepan K
Year: 2020
Journal: Elife
Title: Increased mTOR activity and metabolic efficiency in mouse and human cells containing the African-centric tumor-predisposing p53 variant Pro47Ser.
Volume: 9
•
•
•
•
•
Publication
29330421 | J:260179
First Author: Mok-Lin E
Year: 2018
Journal: Sci Rep
Title: Premature recruitment of oocyte pool and increased mTOR activity in Fmr1 knockout mice and reversal of phenotype with rapamycin.
Volume: 8
Issue: 1
Pages: 588
•
•
•
•
•
Publication
23386687 | J:205463
First Author: Guo Y
Year: 2013
Journal: Mol Cancer Res
Title: Equivalent benefit of rapamycin and a potent mTOR ATP-competitive inhibitor, MLN0128 (INK128), in a mouse model of tuberous sclerosis.
Volume: 11
Issue: 5
Pages: 467-73
•
•
•
•
•
Publication
20142330 | J:158190
First Author: Contreras CM
Year: 2010
Journal: Dis Model Mech
Title: Lkb1 inactivation is sufficient to drive endometrial cancers that are aggressive yet highly responsive to mTOR inhibitor monotherapy.
Volume: 3
Issue: 3-4
Pages: 181-93
•
•
•
•
•
Publication
32341756 | J:310974
First Author: Antoch MP
Year: 2020
Journal: Oncotarget
Title: Superior cancer preventive efficacy of low versus high dose of mTOR inhibitor in a mouse model of prostate cancer.
Volume: 11
Issue: 15
Pages: 1373-1387
•
•
•
•
•
Publication
31377403 | J:353191
 
First Author: LaSarge CL
Year: 2019
Journal: Exp Neurol
Title: Impact of mTOR hyperactive neurons on the morphology and physiology of adjacent neurons: Do PTEN KO cells make bad neighbors?
Volume: 321
Pages: 113029
•
•
•
•
•
Publication
22698676 | J:185581
First Author: Mercier I
Year: 2012
Journal: Am J Pathol
Title: Caveolin-1 and accelerated host aging in the breast tumor microenvironment: chemoprevention with rapamycin, an mTOR inhibitor and anti-aging drug.
Volume: 181
Issue: 1
Pages: 278-93
•
•
•
•
•
Publication
24131995 | J:274438
First Author: Singh PK
Year: 2013
Journal: Mol Biol Cell
Title: Activation of serum/glucocorticoid-induced kinase 1 (SGK1) underlies increased glycogen levels, mTOR activation, and autophagy defects in Lafora disease.
Volume: 24
Issue: 24
Pages: 3776-86
•
•
•
•
•
Publication
34975835 | J:317483
 
First Author: Bou-Tayeh B
Year: 2021
Journal: Front Immunol
Title: Chronic IL-15 Stimulation and Impaired mTOR Signaling and Metabolism in Natural Killer Cells During Acute Myeloid Leukemia.
Volume: 12
Pages: 730970
•
•
•
•
•
Publication
24287405 | J:208075
First Author: Ding X
Year: 2014
Journal: Am J Pathol
Title: Critical role of the mTOR pathway in development and function of myeloid-derived suppressor cells in lal-/- mice.
Volume: 184
Issue: 2
Pages: 397-408
•
•
•
•
•
Publication
22545118 | J:187192
First Author: Yurchenko E
Year: 2012
Journal: PLoS One
Title: Inflammation-driven reprogramming of CD4+ Foxp3+ regulatory T cells into pathogenic Th1/Th17 T effectors is abrogated by mTOR inhibition in vivo.
Volume: 7
Issue: 4
Pages: e35572
•
•
•
•
•
Publication
20473305 | J:161961
First Author: Yoshida T
Year: 2010
Journal: Nat Med
Title: Rtp801, a suppressor of mTOR signaling, is an essential mediator of cigarette smoke-induced pulmonary injury and emphysema.
Volume: 16
Issue: 7
Pages: 767-73
•
•
•
•
•
Publication
26859571 | J:309214
First Author: Syu LJ
Year: 2016
Journal: Oncotarget
Title: Invasive mouse gastric adenocarcinomas arising from Lgr5+ stem cells are dependent on crosstalk between the Hedgehog/GLI2 and mTOR pathways.
Volume: 7
Issue: 9
Pages: 10255-70
•
•
•
•
•
Publication
26971100 | J:338588
First Author: Rocchi A
Year: 2016
Journal: Acta Neuropathol
Title: Glycolytic-to-oxidative fiber-type switch and mTOR signaling activation are early-onset features of SBMA muscle modified by high-fat diet.
Volume: 132
Issue: 1
Pages: 127-44
•
•
•
•
•
Publication
29411774 | J:275563
First Author: Zhao Y
Year: 2018
Journal: Mucosal Immunol
Title: GPR43 mediates microbiota metabolite SCFA regulation of antimicrobial peptide expression in intestinal epithelial cells via activation of mTOR and STAT3.
Volume: 11
Issue: 3
Pages: 752-762
•
•
•
•
•
Publication
32296308 | J:341882
 
First Author: Lieberman OJ
Year: 2020
Journal: Front Cell Neurosci
Title: mTOR Suppresses Macroautophagy During Striatal Postnatal Development and Is Hyperactive in Mouse Models of Autism Spectrum Disorders.
Volume: 14
Pages: 70
•
•
•
•
•
Publication
20656472 | J:164455
First Author: Habib SL
Year: 2010
Journal: Eur J Cancer
Title: Novel mechanism of reducing tumourigenesis: upregulation of the DNA repair enzyme OGG1 by rapamycin-mediated AMPK activation and mTOR inhibition.
Volume: 46
Issue: 15
Pages: 2806-20
•
•
•
•
•
Publication
23348097 | J:199040
First Author: Wang HL
Year: 2013
Journal: Biochim Biophys Acta
Title: XLID CUL4B mutants are defective in promoting TSC2 degradation and positively regulating mTOR signaling in neocortical neurons.
Volume: 1832
Issue: 4
Pages: 585-93
•
•
•
•
•
Publication
21941369 | J:203081
First Author: Ng TL
Year: 2012
Journal: Cell Death Differ
Title: The AMPK stress response pathway mediates anoikis resistance through inhibition of mTOR and suppression of protein synthesis.
Volume: 19
Issue: 3
Pages: 501-10
•
•
•
•
•




MouseMine is a collaboration between MGI at The Jackson Laboratory and the InterMine project at the Cambridge Systems Biology Centre. MouseMine is funded through a grant from the NIH/NHGRI.The Jackson Laboratory makes no representation about the suitability or accuracy of this software or data for any purpose, and makes no warranties, either express or implied, including merchantability and fitness for a particular purpose or that the use of this software or data will not infringe any third party patents, copyrights, trademarks, or other rights. the software and data are provided "as is". This software and data are provided to enhance knowledge and encourage progress in the scientific community and are to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of the Jackson Laboratory.

Copyright © 2017 by The Jackson Laboratory. All Rights Reserved

© 2002 - 2017 Department of Genetics, University of Cambridge, Downing Street,
Cambridge CB2 3EH, United Kingdom